The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 0.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 13.50 (4.712%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 286.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading update

6 Nov 2018 07:00

RNS Number : 4119G
Synthomer PLC
06 November 2018
 

November 6th 2018

Synthomer plc

Q3 Trading update

Solid Q3 performance; Full Year 2018 outlook unchanged

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the third quarter ('Q3') ended September 30th 2018.

Trading

Europe and North America:

Europe and North America reported a solid quarter's results. Excluding sales volumes associated with Pischelsdorf, which was acquired in February 2018, volumes were slightly lower than the comparative Q3 period. Unit margins, excluding Pischelsdorf, were slightly above Q3 2017, with all segments apart from Paper showing a positive movement reflecting the benefits of further investment and increased efficiencies across the business.

Asia and Rest of World:

Asia and Rest of World continued to grow in line with our expectations. Nitrile Latex volumes were slightly ahead of a strong comparative period in Q3 2017. Nitrile Latex unit margins were also higher than the comparative period and in line with unit margins in H1 2018.

The expansion of our Pasir Gudang Nitrile Latex plant was successfully commissioned on time during September 2018. The plant will produce saleable products for customers and make a small contribution to the Group in Q4. Demand for Nitrile Latex remains robust and we have initiated our preliminary work for a further 60kt expansion at Pasir Gudang during 2020.

Financial Position

At September 30th, the Group had net debt of £256m (Q3 2017: £232m), with the increase since June 30th reflecting the planned step up in capital expenditure in H2 2018 (£20m), further investment in working capital (£40m) and the 2017 final dividend (£29m). Going forward, working capital is expected to remain at circa 10% of sales.

FY 2018 Outlook Unchanged

Synthomer's product and geographic diversity means that we are well positioned to withstand the challenging macroeconomic and political environment and, along with the good performance in the first 9 months of the year, the Board's expectations for Full Year 2018 remain unchanged.

Organisational Structure Change

In order to accelerate sales growth, sharpen our commercial focus and drive operational efficiencies, the Group will be reorganised from January 2019. Three new business groups will be created: Performance Elastomers (Styrene Butadiene Rubber and Nitrile Butadiene Latex), Functional Solutions (Dispersions) and Specialities.

The new structure will enable Synthomer to better leverage its global product portfolio and customer relationships, better exploit its R&D capability within chemistries, and bring greater operational focus to production sites.

The new structure combines sales, marketing, research and production by business group into dedicated global teams whilst retaining very strong regional strength and local focus. The Group will report FY 2018 numbers under the existing geographic reporting structure and at the same time publish certain segmental information under the new structure, which will then be adopted on a permanent basis going forward.

ENDS

 

Enquiries:

Calum MacLean, Chief Executive Officer

+44 1279 436 211

Stephen Bennett, Chief Financial Officer

 

Charles Armitstead, Teneo

+44 203 603 5220

 

The Company will hold a conference call for investors and analysts at 0800 GMT today.

Please dial +44 3333000804 entering conference ID: 31828488# to gain access to the call.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUVOKRWRAARAA
Date   Source Headline
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.